by GlobeNewsWire | Jan 4, 2016 | Globe Newswire, GNW Alerts
SILVER SPRING, Md., Jan. 04, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Dec 15, 2015 | Globe Newswire
SILVER SPRING, Md., Dec. 15, 2015 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Oct 5, 2015 | Featured, Globe Newswire, Health Stock, Pharmaceutical
SILVER SPRING, Md., Oct. 05, 2015 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Aug 25, 2015 | Blog, Bold Stocks, Bold Stocks Feature, Feature Box, Featured, Globe Newswire, Medical, Medical Marijuana, Medical Stocks
PharmaCyte Biotech Announces Successful Completion of Interim Audit of GMP Facility for the Production of Cell-in-a-Box for Clinical TrialsSILVER SPRING, Md., Aug. 25, 2015 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology...